Lipidomic architecture shared by subclinical markers of osteoporosis and atherosclerosis: The Cardiovascular Risk in Young Finns Study DOI Creative Commons
Binisha H. Mishra, Pashupati P. Mishra, Nina Mononen

et al.

Bone, Journal Year: 2019, Volume and Issue: 131, P. 115160 - 115160

Published: Nov. 20, 2019

Studies have shown that osteoporosis and atherosclerosis are comorbid conditions sharing common risk factors pathophysiological mechanisms. Understanding these is crucial in order to develop shared methods for stratification, prevention, diagnosis treatment. The aim of this study was apply a system-level bioinformatics approach lipidome-wide data pinpoint the lipidomic architecture jointly associated with surrogate markers complex diseases. based on Cardiovascular Risk Young Finns Study cohort from 2007 follow-up (n = 1494, aged 30–45 years, women: 57%). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) used analyse serum lipidome, involving 437 molecular lipid species. subclinical osteoporotic included indices bone mineral density content, measured using peripheral quantitative computer tomography distal shaft sites both tibia radius. atherosclerotic carotid bulbus intima media thickness high-resolution ultrasound. Weighted co-expression network analysis performed identify networks densely interconnected species (i.e. modules) atherosclerosis. levels (lipid profiles) each modules were summarized by first principal component termed as module eigenlipid. Then, Pearson's correlation (r) calculated between eigenlipids markers. Lipid significantly correlated considered be related comorbidities. hypothesis profiles constituent joint effects tested multivariate variance (MANOVA). Among twelve studied modules, we identified one 105 (r 0.24, p-value 2 × 10−20) 0.16, 10−10). majority belonged glycerolipid 60), glycerophospholipid 13) sphingolipid 29) classes. also enriched ceramides 20), confirming their significance cardiovascular outcomes suggesting role top three 37 statistically significant (adjusted < 0.05) within all triacylglycerols (TAGs) – TAG(18:0/18:0/18:1) an adjusted 8.6 10−8, TAG(18:0/18:1/18:1) 3.7 10−6, TAG(16:0/18:0/18:1) 8.5 10−6. This novel Alterations metabolism and, more specifically, TAG lipids may provide potential new biomarkers testing comorbidities, opening avenues emergence dual-purpose prevention measures.

Language: Английский

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis DOI Creative Commons
Baihui Zhang, Fan Yin, Yanan Qiao

et al.

Frontiers in Molecular Biosciences, Journal Year: 2022, Volume and Issue: 9

Published: May 25, 2022

Cardiovascular disease (CVD) is still the leading cause of death globally, and atherosclerosis main pathological basis CVDs. Low-density lipoprotein cholesterol (LDL-C) a strong causal factor atherosclerosis. However, first-line lipid-lowering drugs, statins, only reduce approximately 30% CVD risk. Of note, atherosclerotic (ASCVD) cannot be eliminated in great number patients even their LDL-C levels meet recommended clinical goals. Previously, whether elevated plasma level triglyceride causally associated with ASCVD has been controversial. Recent genetic epidemiological studies have demonstrated that triglyceride-rich (TGRL) are risk factors residual ASCVD. TGRLs metabolites can promote via modulating inflammation, oxidative stress, formation foam cells. In this article, we will make short review TG TGRL metabolism, display evidence association between ASCVD, summarize atherogenic metabolites, discuss current findings advances TG-lowering therapies. This provides information useful for researchers field as well pharmacologists clinicians.

Language: Английский

Citations

35

Hypertriglyceridemia - Common Causes, Prevention and treatment Strategies DOI
Katarzyna Rygiel

Current Cardiology Reviews, Journal Year: 2018, Volume and Issue: 14(1), P. 67 - 76

Published: March 2, 2018

Background: Prevention and treatment of dyslipidemias represent the key issues Cardiovascular Disease (CVD) prophylaxis. Consequently, effective management different types lipid disorders, including hypertriglyceridemia, should be a priority for healthcare practitioners (e.g.: cardiology endocrinology specialists, primary care physicians, dietitians, pharmacists), who provide medical care, as well patients, receive this need to directly engaged in it, order improve their outcomes. The aim review is facilitate translation current trends hypertriglyceridemia into daily practice. article focuses on common causes consequences discusses diagnostic evaluation therapeutic options patients with high Triglyceride (TG) levels CVD risk. Conclusion: This presents main practice-related strategies, based guidelines risk, according European Society Cardiology (ESC), Atherosclerosis (EAS), American College (ACC)/American Heart Association (AHA), both non-pharmacological, pharmacological approaches. It also addresses beneficial impact pharmaceutical Care (PC) interventions clinical outcomes disorders risk (in light Randomized Controlled Trials (RCT) data), underlines importance close cooperation between physicians pharmacists, manage such patients. Keywords: Diseases (CVD), dyslipidemia, patient management, Pharmaceutical (PC), levels.

Language: Английский

Citations

49

High-Fat Diet during Mouse Pregnancy Impairs Fetal Heart Development DOI Open Access

Kaixin Ge,

Diyaerjiang Aierken,

Defang Deng

et al.

International Heart Journal, Journal Year: 2025, Volume and Issue: 66(1), P. 144 - 156

Published: Jan. 30, 2025

Maternal overnutrition correlates with detrimental outcomes in offspring. However, the specific effects of gestational exposure to a high-fat diet (HFD) on fetal development remain unclear. This study aimed elucidate developmental phenotypes neonatal organs and cardiomyocytes mice exposed HFD, revealing growth retardation notable reduction cardiomyocyte cell cycle activity. In this study, an HFD model was used investigate maternal offspring development. Defective observed offspring, severe restriction proliferation noted as result HFD. Based evidence, we detected Moreover, RNA sequencing analysis revealed that diminished fatty acid metabolism, enhanced inflammatory response, upregulated transcription genes involved Tp53-regulated arrest postnatal day 0 (P0) cardiomyocytes. Furthermore, our results showed during gestation are profound normal lactation feeding after delivery cannot help adult recover from defective heart These findings highlight diverse pathways affected by particularly implicating potential TP53-dependent mechanism contributing cardiac defects

Language: Английский

Citations

0

Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 DOI Creative Commons

Mira Rosenblat,

Raymond Coleman,

Srinivasa T. Reddy

et al.

Journal of Lipid Research, Journal Year: 2008, Volume and Issue: 50(5), P. 870 - 879

Published: Dec. 17, 2008

This study questioned the role of paraoxonase 2 (PON2) in attenuation macrophage lipids accumulation. Mouse peritoneal macrophages (MPMs) harvested from PON2-deficient mice versus control C57BL/6 mice, look like foam cells and were larger size filled with lipid droplets. Macrophage triglyceride (but not cholesterol) content, biosynthesis rate, microsomal acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) activity (not mRNA protein) MPM all significantly increased by 4.6-, 3.6-, 4.4-fold, respectively. Similarly, DGAT1 cellular content decreased human PON2-transfected as well upon incubation recombinant PON2. In above experimental systems, PON2 also oxidative state. Incubation free radicals generator 2,2'-amidinopropane hydrochloride stress 2.2- 3.4-fold, respectively, whereas microsomes superoxide dismutase 40%. We thus conclude that attenuates accumulation cell formation via inhibition activity, which appears to be sensitive

Language: Английский

Citations

56

Lipidomic architecture shared by subclinical markers of osteoporosis and atherosclerosis: The Cardiovascular Risk in Young Finns Study DOI Creative Commons
Binisha H. Mishra, Pashupati P. Mishra, Nina Mononen

et al.

Bone, Journal Year: 2019, Volume and Issue: 131, P. 115160 - 115160

Published: Nov. 20, 2019

Studies have shown that osteoporosis and atherosclerosis are comorbid conditions sharing common risk factors pathophysiological mechanisms. Understanding these is crucial in order to develop shared methods for stratification, prevention, diagnosis treatment. The aim of this study was apply a system-level bioinformatics approach lipidome-wide data pinpoint the lipidomic architecture jointly associated with surrogate markers complex diseases. based on Cardiovascular Risk Young Finns Study cohort from 2007 follow-up (n = 1494, aged 30–45 years, women: 57%). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) used analyse serum lipidome, involving 437 molecular lipid species. subclinical osteoporotic included indices bone mineral density content, measured using peripheral quantitative computer tomography distal shaft sites both tibia radius. atherosclerotic carotid bulbus intima media thickness high-resolution ultrasound. Weighted co-expression network analysis performed identify networks densely interconnected species (i.e. modules) atherosclerosis. levels (lipid profiles) each modules were summarized by first principal component termed as module eigenlipid. Then, Pearson's correlation (r) calculated between eigenlipids markers. Lipid significantly correlated considered be related comorbidities. hypothesis profiles constituent joint effects tested multivariate variance (MANOVA). Among twelve studied modules, we identified one 105 (r 0.24, p-value 2 × 10−20) 0.16, 10−10). majority belonged glycerolipid 60), glycerophospholipid 13) sphingolipid 29) classes. also enriched ceramides 20), confirming their significance cardiovascular outcomes suggesting role top three 37 statistically significant (adjusted < 0.05) within all triacylglycerols (TAGs) – TAG(18:0/18:0/18:1) an adjusted 8.6 10−8, TAG(18:0/18:1/18:1) 3.7 10−6, TAG(16:0/18:0/18:1) 8.5 10−6. This novel Alterations metabolism and, more specifically, TAG lipids may provide potential new biomarkers testing comorbidities, opening avenues emergence dual-purpose prevention measures.

Language: Английский

Citations

30